$TLTFF The Gold Standard for NMIBC NON-RESPONSE!!One dozen undertreated pivph2 patients, with 8 of 12 getting the ful dose on the second round.
What a key piece of info!
The 67% CR from on treatmeant at 18/24 months!
Thems the real data to be a lookin at...
no new info from tltff sicne nov 29 2021.
The FDA wil be BTD consider on 2022 data to date.